NCT00895271View on ClinicalTrials.gov

Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders

Enrolling by invitationOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

June 10, 2009

Conditions

Primary ImmunodeficiencyDOCK8Virus Susceptibility

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00895271 - Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders | Biotech Hunter | Biotech Hunter